Sitemap
December 13, 2008 Articles
Filter by Available Specialty
- Genotype testing may predict efficacy of tamoxifen
- Incident rate dropped sharply after patients stopped estrogen with progestin therapy
- Lapatinib plus letrozole delayed progression in metastatic HER-2–positive disease
- Recurrence score predicted distant recurrence in patients treated with tamoxifen or anastrozole
- Tamoxifen reduced breast density, leading to reduced breast cancer risk